EUVIMEDOpdag EUVIMED
Crossref

Limosilactobacillus reuteri RE225 alleviates gout by modulating the TLR4 / MyD88 / NF ‐ κ B inflammatory pathway and the Nrf2/ HO ‐1 oxidative stress pathway, and by regulating gut microbiota

Yang Qin, Yucong Zhou, Jiayi Xiong, Chenyang Lu, Jun Zhou, Xiurong Su, Jiaojiao Han iD

Journal of the Science of Food and Agriculture · 2025

DOI: 10.1002/jsfa.13908 ↗

At a glance

Journal article in Journal of the Science of Food and Agriculture, 2025. Written by Yang Qin and 6 co-authors. Institution: State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, School of Marine Science, Ningbo University…. Major MEDLINE topics: Gastrointestinal Microbiome, Limosilactobacillus reuteri, Toll-Like Receptor 4, NF-kappa B. Cited 19 times so far (Crossref); 45 references. Funded by: General Project of Zhejiang Provincial Department of Education (Y202146257), Natural Science Foundation of Zhejiang Province (LTGC23C190001).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND Gout poses a significant health threat. The use of Lactobacillus from the gut microbiota is one potential remedy. However, the intricate molecular mechanisms governing the impact of Lactobacillus on gout remain largely uncharted. In this study, a strain of Limosilactobacillus reuteri RE225 was separated from the gut of mice and colitis was treated with polypeptide intervention. RESULTS Limosilactobacillus reuteri RE225 reduced foot tumefaction markedly in mice with gout and extended the pain threshold time in their feet. It also improved the health of gut microbiota. Intervention with L. reuteri RE225 also suppressed the TLR4/MyD88/NF‐ κ B and nuclear factor erythroid 2‐related factor 2 (Nrf2)/heme oxygenase‐1 (HO‐1) pathways in the mice, reduced the levels of pro‐inflammatory cytokines – interleukin 1 β (IL‐1 β ), interleukin 6 (IL‐6), and tumor necrosis factor‐ α (TNF‐ α ) – and increased the level of the anti‐inflammatory cytokine interleukin 10 (IL‐10), thereby mitigating inflammation. CONCLUSION This study provides a theoretical basis for the comprehensive development of Limosilactobacillus reuteri and new ideas for the non‐pharmacological treatment of gout. © 2024 Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeLimosilactobacillus reuteriToll-Like Receptor 4NF-kappa BMyeloid Differentiation Factor 88GoutNF-E2-Related Factor 2Oxidative StressProbioticsAnimalsMiceHumansMaleHeme Oxygenase-1Signal TransductionMice, Inbred C57BL

Author keywords

Limosilactobacillus reuterigoutgut microbiotainflammatory pathwaysoxidative stress

Substances

Toll-Like Receptor 4NF-kappa BMyeloid Differentiation Factor 88NF-E2-Related Factor 2Heme Oxygenase-1Tlr4 protein, mouseMyd88 protein, mouse

Authors and institutions

  • State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, School of Marine Science, Ningbo University, Ningbo, China.
  • College of Biological and Environmental Science, Zhejiang Wanli University, Ningbo, China.

ORCID profiles: Jiaojiao Han

Funding

  • General Project of Zhejiang Provincial Department of Education (Y202146257)
  • Natural Science Foundation of Zhejiang Province (LTGC23C190001)

Cite

APA

Qin, Y., Zhou, Y., Xiong, J., Lu, C., Zhou, J., Su, X., & Han, J. (2025). Limosilactobacillus reuteri RE225 alleviates gout by modulating the TLR4 / MyD88 / NF ‐ κ B inflammatory pathway and the Nrf2/ HO ‐1 oxidative stress pathway, and by regulating gut microbiota. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13908

Vancouver

Qin Y, Zhou Y, Xiong J, Lu C, Zhou J, Su X, et al. Limosilactobacillus reuteri RE225 alleviates gout by modulating the TLR4 / MyD88 / NF ‐ κ B inflammatory pathway and the Nrf2/ HO ‐1 oxidative stress pathway, and by regulating gut microbiota. Journal of the Science of Food and Agriculture. 2025. doi:10.1002/jsfa.13908

BibTeX
@article{Qin2025,
  author = {Qin, Yang and Zhou, Yucong and Xiong, Jiayi and Lu, Chenyang and Zhou, Jun and Su, Xiurong and Han, Jiaojiao},
  title = {Limosilactobacillus reuteri RE225 alleviates gout by modulating the TLR4 / MyD88 / NF ‐ κ B inflammatory pathway and the Nrf2/ HO ‐1 oxidative stress pathway, and by regulating gut microbiota},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2025},
  doi = {10.1002/jsfa.13908}
}
Start for free →